Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins rib and α

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3518-3523

  Larsson, Charlotte ^a   Stålhammar Carlemalm, Margaretha ^a   Lindahl, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE IMMUNIZATION; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGENIC VARIATION; ARTICLE; BACTERIUM ISOLATION; CELL SURFACE; CROSS REACTION; ENCAPSULATION; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; STREPTOCOCCUS AGALACTIAE; VACCINATION;

EID: 0029849096     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3518-3523.1996     Document Type: Article

References (35)

1. Ala'Aldeen, D. A. A., and C. E. Hormaeche (ed.). 1995. Molecular and clinical aspects of bacterial vaccine development. John Wiley & Sons, Chichester, U.K.
2. Ala'Aldeen, D. A. A., P. Stevenson, E. Griffiths, A. R. Gorringe, L. I. Irons, A. Robinson, S. Hyde, and S. P. Borriello. 1994. Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect. Immun. 62:2984-2990.
3. Alexander, J. E., R. A. Lock, C. C. A. M. Peeters, J. T. Poolman, P. W. Andrew, T. J. Mitchell, D. Hansman, and J. C. Paton. 1994. Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae. Infect. Immun. 62:5683-5688.
4. Austrian, R. 1989. Pneumococcal polysaccharide vaccines. Rev. Infect. Dis. 11:S598-S602.
5. Baker, C. J. 1993. Vaccine prevention of group B streptococcal disease. Pediatr. Ann. 22:711-714.
6. Baker, C. J., and M. S. Edwards. 1995. Group B streptococcal infections, p. 980-1054. In J. S. Remington and J. O. Klein (ed.), Infectious diseases of the fetus and newborn infant. W. B. Saunders, Philadelphia.
7. Bevanger, L. 1983. Ibc proteins as serotype markers of group B streptococci. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 91:231-234.
8. Bevanger, L., and A. I. Naess. 1985. Mouse-protective antibodies against the Ibc proteins of group B streptococci. Acta Pathol. Microbiol. Immunol. Scand. Sect. B 93:121-124.
9. Farley, M. M., R. C. Harvey, T. Stull, J. D. Smith, A. Schuchat, J. D. Wenger, and D. S. Stephens. 1993. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N. Engl. J. Med. 328: 1807-1811.
10. Finne, J., M. Leinonen, and P. H. Mäkelä. 1983. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet ii:355-357.
11. Frasch, C. E. 1989. Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2:S134-S138.
12. Heden, L. O., E. Frithz, and G. Lindahl. 1991. Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity. Eur. J. Immunol. 21:1481-1490.
13. Jerlström, P. G., G. S. Chhatwal, and K. N. Timmis. 1991. The IgA-binding beta antigen of the c protein complex of Group B streptococci: sequence determination of its gene and detection of two binding regions. Mol. Microbiol. 5:843-849.
14. Jourdian, G. W., L. Dean, and S. Roseman. 1971. The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J. Biol. Chem. 246:430-435.
15. Lancefield, R. C., M. McCarty, and W. N. Everly. 1975. Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J. Exp. Med. 142:165-179.
16. Langermann, S., S. R. Palaszynski, J. E. Burlein, S. Koenig, M. S. Hanson, D. E. Briles, and C. K. Stover. 1994. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. J. Exp. Med. 180:2277-2286.
17. Madoff, L. C., S. Hori, J. L. Michel, C. J. Baker, and D. L. Kasper. 1991. Phenotypic diversity in the alpha C protein of group B streptococci. Infect. Immun. 59:2638-2644.
18. Madoff, L. C., J. L. Michel, E. W. Gong, A. K. Rodewald, and D. L. Kasper. 1992. Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein. Infect. Immun. 60:4989-4994.
19. Madoff, L. C., L. C. Paoletti, J. Y. Tai, and D. L. Kasper. 1994. Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes. J. Clin. Invest. 94:285-292.
20. Marques, M. B., D. L. Kasper, A. Shroff, F. Michon, H. J. Jennings, and M. R. Wessels. 1994. Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Infect. Immun. 62:1593-1599.
21. Michel, J. L., L. C. Madoff, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1991. C proteins of group B streptococci, p. 214-218. In G. M. Dunny, P. P. Cleary, and L. L. McKay (ed.), Genetics and molecular biology of streptococci, lactococci, and enterococci. American Society for Microbiology, Washington, D.C.
22. Michel, J. L., L. C. Madoff, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1991. Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity. Infect. Immun. 59:2023-2028.
23. Michel, J. L., L. C. Madoff, K. Olson, D. E. Kling, D. L. Kasper, and F. M. Ausubel. 1992. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc. Natl. Acad. Sci. USA 89:10060-10064.
24. Michon, F., E. Katzenellenbogen, D. L. Kasper, and H. J. Jennings. 1987. Structure of the complex group-specific polysaccharide of group B Streptococcus. Biochemistry 26:476-486.
25. Musser, J. M., S. J. Mattingly, R. Quentin, A. Goudeau, and R. K. Selander. 1989. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc. Natl. Acad. Sci. USA 86:4731-4735.
26. Paoletti, L. C., M. R. Wessels, A. K. Rodewald, A. A. Shroff, H. J. Jennings, and D. L. Kasper, 1994. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 62:3236-3243.
27. Pritchard, D. G., B. M. Gray, and M. L. Egan. 1992. Marine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides. Infect. Immun. 60:1598-1602.
28. 27a. Stålhammar-Carlemalm, M., and G. Lindahl. Unpublished data.
29. Stålhammar-Carlemalm, M., L. Stenberg, and G. Lindahl. 1993. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177:1593-1603.
30. Stenberg, L., P. O'Toole, and G. Lindahl. 1992. Many group A streptococcal strains express two different immunoglobulin-binding proteins, encoded by closely linked genes: characterization of the proteins expressed by four strains of different M-type. Mol. Microbiol. 6:1185-1194.
31. Tamura, G. S., J. M. Kuypers, S. Smith, H. Raff, and C. E. Rubens. 1994. Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect. Immun. 62:2450-2458.
32. Wästfelt, M., M. Stålhammar-Carlemalm, A.-M. Delisse, T. Cabezon, and G. Lindahl. Identification of a family of streptococcal surface proteins with extremely repetitive structure. J. Biol. Chem., in press.
33. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, K. Holme, and H. J. Jennings. 1991. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 86:1428-1433.
34. Wessels, M. R., C. E. Rubens, V. J. Benedi, and D. L. Kasper. 1989. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc. Natl. Acad. Sci. USA 86:8983-8987.
35. Zangwill, K. M., A. Schuchat, and J. D. Wenger. 1992. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Morbid. Mortal. Weekly Rep. 41:25-32.